{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T14:52:37Z","timestamp":1785509557135,"version":"3.56.0"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T00:00:00Z","timestamp":1637798400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.jdcr.2021.11.022","type":"journal-article","created":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T01:43:59Z","timestamp":1639619039000},"page":"44-46","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Effective treatment of mogamulizumab-induced head and neck dermatitis with\u00a0fluconazole in a patient with peripheral T-Cell lymphoma"],"prefix":"10.1016","volume":"20","author":[{"given":"Ishan","family":"Asokan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanminder","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Moesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonhan","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleg E.","family":"Akilov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdcr.2021.11.022_bib1","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s12185-010-0513-0","article-title":"Linkage of expression of chemokine receptors (CXCR3 and CCR4) and cytotoxic molecules in peripheral T cell lymphoma, not otherwise specified and ALK-negative anaplastic large cell lymphoma","volume":"91","author":"Asano","year":"2010","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jdcr.2021.11.022_bib2","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1200\/JCO.2013.52.0924","article-title":"Multicenter phase II study of mogamulizumab (KW-0761), a defucosylated anti-cc chemokine receptor 4 antibody, in patients with relapsed peripheral T-cell lymphoma and cutaneous T-cell lymphoma","volume":"32","author":"Ogura","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jdcr.2021.11.022_bib3","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.cell.2018.10.022","article-title":"Impact of genetic polymorphisms on human immune cell gene expression","volume":"175","author":"Schmiedel","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.jdcr.2021.11.022_bib4","doi-asserted-by":"crossref","first-page":"17945","DOI":"10.1073\/pnas.1316796110","article-title":"Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans","volume":"110","author":"Sugiyama","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jdcr.2021.11.022_bib5","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.4049\/jimmunol.0903144","article-title":"Skin inflammation arising from cutaneous regulatory T cell deficiency leads to impaired viral immune responses","volume":"185","author":"Freyschmidt","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.jdcr.2021.11.022_bib6","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/S1470-2045(18)30379-6","article-title":"Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial","volume":"19","author":"Kim","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jdcr.2021.11.022_bib7","article-title":"Mogamulizumab efficacy is underscored by its associated rash that mimics cutaneous T-cell lymphoma: a retrospective single-centre case series","author":"Trum","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jdcr.2021.11.022_bib8","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jdcr.2020.12.035","article-title":"Mogamulizumab-induced interface dermatitis drug rash treated successfully with methotrexate and extracorporeal photopheresis in a patient with Sezary syndrome","volume":"9","author":"Breen","year":"2021","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.jdcr.2021.11.022_bib9","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1001\/jamadermatol.2019.0369","article-title":"Mogamulizumab-associated cutaneous granulomatous drug eruption mimicking mycosis fungoides but possibly indicating durable clinical response","volume":"155","author":"Chen","year":"2019","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jdcr.2021.11.022_bib10","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00262-017-2090-z","article-title":"Therapeutic reduction of cell-mediated immunosuppression in mycosis fungoides and Sezary syndrome","volume":"67","author":"Geskin","year":"2018","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.jdcr.2021.11.022_bib11","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.4049\/jimmunol.1502139","article-title":"Cutting edge: regulatory T cells facilitate cutaneous wound healing","volume":"196","author":"Nosbaum","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/j.jdcr.2021.11.022_bib12","doi-asserted-by":"crossref","first-page":"e12746","DOI":"10.1111\/cmi.12746","article-title":"The Yin and Yang of regulatory T cells in infectious diseases and avenues to target them","volume":"19","author":"Stephen-Victor","year":"2017","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.jdcr.2021.11.022_bib13","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s12185-015-1811-3","article-title":"Colitis mimicking graft-versus-host disease during treatment with the anti-CCR4 monoclonal antibody, mogamulizumab","volume":"102","author":"Ishitsuka","year":"2015","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jdcr.2021.11.022_bib14","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jaad.2014.04.045","article-title":"A retrospective descriptive study of oral azole antifungal agents in patients with patch test-negative head and neck predominant atopic dermatitis","volume":"71","author":"Kaffenberger","year":"2014","journal-title":"J Am Acad Dermatol"}],"updated-by":[{"DOI":"10.1016\/j.jdcr.2022.02.012","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000}}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512621008754?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512621008754?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T19:44:07Z","timestamp":1645127047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512621008754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":14,"alternative-id":["S2352512621008754"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2021.11.022","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.jdcr.2022.02.012","asserted-by":"object"}]},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effective treatment of mogamulizumab-induced head and neck dermatitis with\u00a0fluconazole in a patient with peripheral T-Cell lymphoma","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2021.11.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the American Academy of Dermatology, Inc. Published by Elsevier, Inc.","name":"copyright","label":"Copyright"}]}}